Lexicon Pharmaceuticals Inc
F:LX31
Lexicon Pharmaceuticals Inc
F:LX31
Price:
2.894
EUR
-2.69%
Market Closed
Market Cap:
€418.1m
Balance Sheet
Balance Sheet Decomposition
Lexicon Pharmaceuticals Inc
Lexicon Pharmaceuticals Inc
Balance Sheet Decomposition is not available for
Lexicon Pharmaceuticals Inc
Lexicon Pharmaceuticals Inc
Balance Sheet
Lexicon Pharmaceuticals Inc
Lexicon Pharmaceuticals Inc
Currency: USD
| Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
39
|
36
|
15
|
22
|
30
|
23
|
86
|
101
|
47
|
186
|
30
|
38
|
137
|
203
|
47
|
62
|
80
|
36
|
126
|
64
|
46
|
22
|
67
|
34
|
|
| Cash Equivalents |
39
|
36
|
15
|
22
|
30
|
23
|
86
|
101
|
47
|
186
|
30
|
38
|
137
|
203
|
47
|
62
|
80
|
36
|
126
|
64
|
46
|
22
|
67
|
34
|
|
| Short-Term Investments |
54
|
111
|
73
|
78
|
50
|
236
|
17
|
62
|
164
|
95
|
192
|
91
|
202
|
318
|
300
|
249
|
80
|
236
|
26
|
23
|
92
|
148
|
171
|
62
|
|
| Total Receivables |
5
|
7
|
6
|
3
|
1
|
2
|
1
|
1
|
1
|
0
|
1
|
1
|
1
|
1
|
8
|
5
|
6
|
57
|
0
|
0
|
0
|
1
|
3
|
2
|
|
| Accounts Receivables |
5
|
7
|
5
|
3
|
1
|
2
|
1
|
1
|
1
|
0
|
1
|
1
|
1
|
1
|
8
|
5
|
6
|
57
|
0
|
0
|
0
|
1
|
3
|
2
|
|
| Other Receivables |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
5
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
34
|
18
|
5
|
4
|
4
|
4
|
6
|
7
|
3
|
4
|
7
|
5
|
29
|
10
|
4
|
4
|
3
|
5
|
5
|
2
|
3
|
5
|
5
|
3
|
|
| Total Current Assets |
133
|
172
|
99
|
106
|
86
|
265
|
109
|
170
|
215
|
286
|
231
|
135
|
369
|
532
|
358
|
322
|
173
|
338
|
158
|
89
|
141
|
177
|
246
|
102
|
|
| PP&E Net |
37
|
84
|
85
|
85
|
78
|
71
|
65
|
59
|
53
|
46
|
43
|
41
|
1
|
21
|
19
|
18
|
16
|
16
|
2
|
4
|
4
|
8
|
7
|
9
|
|
| PP&E Gross |
37
|
84
|
85
|
85
|
78
|
71
|
65
|
59
|
53
|
46
|
43
|
41
|
1
|
21
|
19
|
18
|
16
|
16
|
2
|
4
|
4
|
8
|
7
|
9
|
|
| Accumulated Depreciation |
20
|
32
|
42
|
48
|
57
|
65
|
71
|
76
|
80
|
81
|
83
|
82
|
36
|
59
|
60
|
59
|
60
|
62
|
6
|
5
|
4
|
5
|
2
|
3
|
|
| Intangible Assets |
4
|
3
|
2
|
1
|
0
|
0
|
0
|
0
|
54
|
54
|
54
|
54
|
53
|
53
|
53
|
52
|
50
|
20
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Goodwill |
26
|
26
|
26
|
26
|
26
|
26
|
26
|
26
|
45
|
45
|
45
|
45
|
45
|
45
|
45
|
45
|
45
|
45
|
45
|
45
|
45
|
45
|
45
|
45
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
56
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
1
|
0
|
1
|
1
|
1
|
8
|
6
|
4
|
1
|
0
|
0
|
0
|
3
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
5
|
1
|
0
|
29
|
|
| Other Assets |
26
|
26
|
26
|
26
|
26
|
26
|
26
|
26
|
45
|
45
|
45
|
45
|
45
|
45
|
45
|
45
|
45
|
45
|
45
|
45
|
45
|
45
|
45
|
45
|
|
| Total Assets |
202
N/A
|
284
+41%
|
212
-25%
|
219
+3%
|
190
-13%
|
369
+94%
|
262
-29%
|
258
-1%
|
367
+42%
|
431
+17%
|
372
-14%
|
274
-26%
|
471
+72%
|
652
+38%
|
476
-27%
|
437
-8%
|
284
-35%
|
418
+47%
|
204
-51%
|
137
-33%
|
194
+42%
|
229
+18%
|
298
+30%
|
185
-38%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
4
|
6
|
8
|
7
|
7
|
7
|
8
|
6
|
3
|
6
|
8
|
10
|
13
|
20
|
53
|
39
|
18
|
12
|
6
|
9
|
10
|
14
|
15
|
3
|
|
| Accrued Liabilities |
4
|
5
|
7
|
7
|
7
|
9
|
7
|
6
|
6
|
14
|
9
|
8
|
10
|
25
|
32
|
12
|
15
|
42
|
30
|
11
|
12
|
15
|
28
|
11
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
5
|
5
|
1
|
1
|
1
|
39
|
1
|
1
|
2
|
2
|
20
|
2
|
16
|
14
|
1
|
11
|
12
|
0
|
0
|
0
|
0
|
5
|
|
| Other Current Liabilities |
13
|
21
|
20
|
39
|
31
|
18
|
6
|
1
|
0
|
0
|
0
|
0
|
2
|
77
|
63
|
40
|
3
|
0
|
0
|
3
|
0
|
3
|
2
|
2
|
|
| Total Current Liabilities |
21
|
32
|
39
|
58
|
46
|
35
|
21
|
51
|
11
|
21
|
18
|
19
|
45
|
123
|
165
|
106
|
37
|
65
|
47
|
22
|
23
|
32
|
45
|
21
|
|
| Long-Term Debt |
4
|
56
|
33
|
32
|
31
|
31
|
30
|
29
|
27
|
24
|
22
|
20
|
88
|
101
|
85
|
232
|
244
|
234
|
0
|
0
|
49
|
100
|
100
|
49
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
19
|
19
|
19
|
19
|
19
|
19
|
19
|
6
|
6
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
30
|
10
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
7
|
30
|
19
|
43
|
27
|
17
|
15
|
15
|
63
|
69
|
46
|
46
|
36
|
124
|
50
|
25
|
24
|
1
|
1
|
1
|
5
|
5
|
7
|
7
|
|
| Total Liabilities |
32
N/A
|
118
+270%
|
90
-23%
|
133
+47%
|
105
-21%
|
113
+8%
|
76
-33%
|
94
+24%
|
120
+28%
|
133
+11%
|
105
-21%
|
104
-1%
|
187
+80%
|
366
+95%
|
318
-13%
|
368
+16%
|
311
-16%
|
301
-3%
|
47
-84%
|
23
-51%
|
77
+231%
|
136
+77%
|
152
+12%
|
77
-49%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
150
|
214
|
261
|
297
|
352
|
411
|
487
|
570
|
673
|
790
|
900
|
1 004
|
1 104
|
1 109
|
1 250
|
1 365
|
1 472
|
1 341
|
1 400
|
1 488
|
1 590
|
1 767
|
1 967
|
2 018
|
|
| Additional Paid In Capital |
331
|
381
|
383
|
383
|
437
|
667
|
673
|
734
|
920
|
1 087
|
1 167
|
1 175
|
1 390
|
1 398
|
1 411
|
1 436
|
1 448
|
1 462
|
1 561
|
1 609
|
1 709
|
1 863
|
2 117
|
2 130
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
3
|
3
|
2
|
3
|
4
|
5
|
8
|
2
|
3
|
5
|
5
|
|
| Other Equity |
11
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
170
N/A
|
166
-2%
|
122
-27%
|
86
-29%
|
86
0%
|
256
+200%
|
186
-28%
|
164
-12%
|
247
+51%
|
298
+20%
|
267
-10%
|
170
-36%
|
284
+67%
|
286
+1%
|
157
-45%
|
68
-57%
|
26
N/A
|
117
N/A
|
156
+34%
|
114
-27%
|
117
+3%
|
93
-20%
|
146
+57%
|
108
-26%
|
|
| Total Liabilities & Equity |
202
N/A
|
284
+41%
|
212
-25%
|
219
+3%
|
190
-13%
|
369
+94%
|
262
-29%
|
258
-1%
|
367
+42%
|
431
+17%
|
372
-14%
|
274
-26%
|
471
+72%
|
652
+38%
|
476
-27%
|
437
-8%
|
284
-35%
|
418
+47%
|
204
-51%
|
137
-33%
|
194
+42%
|
229
+18%
|
298
+30%
|
185
-38%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
8
|
9
|
9
|
9
|
11
|
20
|
20
|
25
|
48
|
69
|
73
|
73
|
104
|
104
|
104
|
106
|
106
|
106
|
142
|
149
|
189
|
245
|
361
|
363
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
|
Switch to:
Switch to:
See Also
Discover More
